World's largest platform for nanomedicine
What are Lipid Nanoparticles and what makes them so extraordinary? 
Pioneering Genetic Therapies: Unparalleled Role of Lipid Nanoparticles in Overcoming Lung Disease and Vision Impairment 
Top 6 emerging nanomedicine companies of 2024 
RNA Nanomedicine advances by 73% in the Battle Against HIV 
New Regulations in Nanomedicine Affecting Companies: Navigating the Future 
Lipid nanoparticles (LNPs) are tiny, engineered particles made up of lipids (fatty molecules) that are used to deliver therapeutic substances into cells. They are a key technology in the field
A team of researchers working with small-scale drug delivery systems known as lipid nanoparticles has created a novel material that can target the lungs and eyes. This breakthrough is a
Nanotechnology, which is the manipulation of molecules on an atomic scale, has been implemented by companies in medicine, with applications galore – in drug discovery, tissue engineering, imaging and diagnostics.
The realm of medical research has continually sought innovative solutions to combat the Human Immunodeficiency Virus (HIV), a relentless virus that attacks the immune system, specifically targeting white blood cells.
Dive into the complexities of new regulations in nanomedicine affecting companies. Understand the implications, strategies for compliance, and the future of nanotechnology in healthcare.
